HEM1 deficiency disrupts mTORC2 and F-actin control in inherited immunodysregulatory disease

Journal: Science

Published: 2020-07-10

DOI: 10.1126/science.aay5663

Affiliations: 30

Authors: 39

Go to article
Institutions Share
Baylor College of Medicine (BCM), United States of America (USA) 0.17
NIH National Institute of Allergy and Infectious Diseases (NIAID), United States of America (USA) 0.12
NIH NIAID Division of Intramural Research (DIR), United States of America (USA) 0.10
Abu Dhabi Health Services Company (SEHA), United Arab Emirates 0.10
Texas Children's Hospital, BCM, United States of America (USA) 0.07
Iowa State University, United States of America (USA) 0.05
Imagine Institute, France 0.05
Columbia University Irving Medical Center (CUIMC), CU, United States of America (USA) 0.05
University of Pennsylvania (Penn), United States of America (USA) 0.03
Children's Hospital of Philadelphia (CHOP), United States of America (USA) 0.03
Baylor-John Hopkins Center for Mendelian Genomics (BHCMG), United States of America (USA) 0.03
Wake Forest Baptist Health, WFU, United States of America (USA) 0.03
Centre Hospitalier Universitaire de Lille (CHU Lille), France 0.03
Research Institute in Oncology and Hematology (RIOH), Canada 0.03
NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), United States of America (USA) 0.03
Frederick National Laboratory for Cancer Research (FNLCR), United States of America (USA) 0.03
Neomics Pharmaceuticals, LLC., United States of America (USA) 0.01
Children's Mercy Hospitals and Clinics, United States of America (USA) 0.01
University of Missouri-Kansas City (UMKC), United States of America (USA) 0.01
Universidad del Desarrollo (UDD), Chile 0.01
Thomas Jefferson University (TJU), United States of America (USA) 0.01

Return